Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.72B |
| 2 |
Linde
LIN
|
+$1.13B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$633M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$580M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$572M |
Top Sells
| 1 |
Fortive
FTV
|
+$1.06B |
| 2 |
Technology Select Sector SPDR Fund
XLK
|
+$899M |
| 3 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$390M |
| 4 |
Amazon
AMZN
|
+$363M |
| 5 |
Industrial Select Sector SPDR Fund
XLI
|
+$307M |
Sector Composition
| 1 | Technology | 14.52% |
| 2 | Healthcare | 11.16% |
| 3 | Financials | 11.03% |
| 4 | Communication Services | 9.66% |
| 5 | Consumer Discretionary | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Aldeyra Therapeutics
ALDX
$324M
| $53K | ﹤0.01% |
6,440
+73
| +1% | +$601 |
|
3052
eGain
EGAN
$220M
| $53K | ﹤0.01% |
8,132
-9,574
| -54% | -$62.4K |
|
3053
LSB Industries
LXU
$576M
| $53K | ﹤0.01% |
12,636
-27,920
| -69% | -$117K |
|
3054
Mistras Group
MG
$299M
| $53K | ﹤0.01% |
3,664
-5,502
| -60% | -$79.6K |
|
3055
Orion Group Holdings
ORN
$299M
| $53K | ﹤0.01% |
12,409
-29,956
| -71% | -$128K |
|
|
SHYF
3056
DELISTED
The Shyft Group
SHYF
| $53K | ﹤0.01% |
7,282
-6,331
| -47% | -$46.1K |
|
|
STR
3057
DELISTED
Sitio Royalties
STR
| $53K | ﹤0.01% |
1,562
-672
| -30% | -$22.8K |
|
|
MR
3058
DELISTED
Montage Resources Corporation Common Stock
MR
| $53K | ﹤0.01% |
3,412
-4,195
| -55% | -$65.2K |
|
3059
Corbus Pharmaceuticals
CRBP
$116M
| $52K | ﹤0.01% |
301
+296
| +5,920% | +$51.1K |
|
3060
Great Lakes Dredge & Dock
GLDD
$821M
| $52K | ﹤0.01% |
7,886
-55,924
| -88% | -$369K |
|
3061
Immersion
IMMR
$221M
| $52K | ﹤0.01% |
5,893
-17,940
| -75% | -$158K |
|
3062
Syndax Pharmaceuticals
SNDX
$1.34B
| $52K | ﹤0.01% |
11,852
-6,081
| -34% | -$26.7K |
|
3063
TFS Financial
TFSL
$3.75B
| $52K | ﹤0.01% |
3,266
-1,410
| -30% | -$22.4K |
|
3064
Gold Resource Corp
GORO
$133M
| $51K | ﹤0.01% |
12,644
-41,412
| -77% | -$167K |
|
3065
SPDR S&P China ETF
GXC
$502M
| $51K | ﹤0.01% |
603
+476
| +375% | +$40.3K |
|
3066
ProQR Therapeutics
PRQR
$231M
| $51K | ﹤0.01% |
+3,216
| New | +$51K |
|
|
ANAT
3067
DELISTED
American National Group, Inc. Common Stock
ANAT
| $51K | ﹤0.01% |
401
-1,446
| -78% | -$184K |
|
|
ACHN
3068
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $51K | ﹤0.01% |
32,709
-84,694
| -72% | -$132K |
|
3069
Bloom Energy
BE
$15.7B
| $50K | ﹤0.01% |
4,965
+4,865
| +4,865% | +$49K |
|
|
HEPA
3070
DELISTED
Hepion Pharmaceuticals
HEPA
| $50K | ﹤0.01% |
3
+2
| +200% | +$33.3K |
|
3071
iRadimed
IRMD
$907M
| $50K | ﹤0.01% |
2,059
+721
| +54% | +$17.5K |
|
|
NGD
3072
New Gold Inc
NGD
$5.16B
| $50K | ﹤0.01% |
65,947
+26,769
| +68% | +$20.3K |
|
3073
Telecom Argentina
TEO
$3.07B
| $50K | ﹤0.01% |
3,189
-1,610
| -34% | -$25.2K |
|
|
TECX
3074
Tectonic Therapeutic, Inc. Common Stock
TECX
$332M
| $50K | ﹤0.01% |
251
-40
| -14% | -$7.97K |
|
|
NWLI
3075
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $50K | ﹤0.01% |
166
-780
| -82% | -$235K |
|